View Future GrowthNovanta 過去の業績過去 基準チェック /16Novantaは、平均年間2.3%の収益成長を遂げていますが、 Electronic業界の収益は、年間 成長しています。収益は、平均年間3.8% 8.5%収益成長率で 成長しています。 Novantaの自己資本利益率は4.1%であり、純利益率は5.3%です。主要情報2.30%収益成長率1.63%EPS成長率Electronic 業界の成長15.34%収益成長率8.52%株主資本利益率4.10%ネット・マージン5.35%前回の決算情報03 Apr 2026最近の業績更新Reported Earnings • May 12First quarter 2026 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2026 results: EPS: US$0.52 (down from US$0.59 in 1Q 2025). Revenue: US$257.7m (up 10% from 1Q 2025). Net income: US$21.1m (flat on 1Q 2025). Profit margin: 8.2% (down from 9.1% in 1Q 2025). Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Revenue is forecast to grow 5.9% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.お知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026Reported Earnings • Feb 24Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: US$1.47 (down from US$1.78 in FY 2024). Revenue: US$980.6m (up 3.3% from FY 2024). Net income: US$53.8m (down 16% from FY 2024). Profit margin: 5.5% (down from 6.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.9%. Revenue is forecast to grow 6.5% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026Reported Earnings • Nov 04Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: US$0.30 (down from US$0.53 in 3Q 2024). Revenue: US$247.8m (up 1.4% from 3Q 2024). Net income: US$10.7m (down 45% from 3Q 2024). Profit margin: 4.3% (down from 7.9% in 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 9.6% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 4% per year.お知らせ • Oct 08Novanta Inc. to Report Q3, 2025 Results on Nov 04, 2025Novanta Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 04, 2025すべての更新を表示Recent updatesお知らせ • Jun 11Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion.Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion on June 8, 2026. A cash consideration of $1.2 billion will be paid by Novanta Inc. Novanta Inc. will pay a milestone payment of $250 million in the first quarter of 2027. Upon completion of the transaction, Riverpoint Medical will be reported under Novanta’s Medical Solutions operating segment. The transaction will be financed through a combination of cash on hand and Novanta’s existing credit facility, and the recently completed $300 million equity raise. The transaction is subject to customary regulatory approvals and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the third quarter of 2026. The transaction is expected to be immediately accretive in 2026 to Novanta’s Adjusted Diluted Earnings Per Share, and in 2027 accretive to revenue growth rate, Adjusted Gross and EBITDA Margins, Adjusted Diluted Earnings Per Share, and Operating Cash Flows. Robert W. Baird & Co. Incorporated acted as financial advisor for Novanta Inc. Jefferies LLC acted as financial advisor for Riverpoint Medical, LLC. J.P. Morgan Securities LLC acted as financial advisor for Novanta Inc. King & Spalding LLP acted as legal advisor for Novanta Inc. Matthew J. Byron, Melissa Rones, Emily Karlberg, Renata Ferrari, Pamela Glazier, Samer Musallam, Lisa Kaltenbrunner, Emerson Siegle, Deidre Johnson, Ryan Murphey, Rebecca Liu, Heather Sprague, Alison McLaughlin, and Kurt Fowler of Ropes & Gray LLP acted as legal advisor for Novanta Inc. Joshua Klatzkin, Matthew M. Mauney, and Michael Amalfe of Goodwin Procter LLP acted as legal advisor for Riverpoint Medical, LLC.Seeking Alpha • Jun 11Novanta: An Interesting Deal Accelerates GrowthSummary Novanta announced a substantial $1.45B acquisition of Riverpoint Medical, doubling recurring medical consumables revenue and increasing medical end-market concentration to 60%. Riverpoint brings high-margin, fast-growing consumables, with 12-15% organic growth and 40% EBITDA margins, enhancing Novanta's profitability profile. Pro forma leverage rises to 2.7x; a $300M equity raise at a discount offsets some debt but results in 3% dilution. Despite strong execution and growth momentum, Novanta trades at ~40x forward earnings, leading me to remain cautious and await better entry points. Read the full article on Seeking Alphaお知らせ • Jun 10Novanta Inc. announced that it expects to receive $299.99998 million in fundingNovanta Inc. entered into a Securities Purchase Agreement and announced a private placement of 2,142,857 Common Shares of the company at an issue price of $140 for gross proceeds up to $300.0 million on June 8, 2026. The transaction involves participation from institutional and other accredited investors. The private placement is expected to close on or about June 11, 2026, subject to satisfaction of customary closing conditions.ライブニュース • Jun 09Novanta Expands Medical Consumables With US$1.2 Billion Riverpoint Deal and US$300 Million Capital RaiseNovanta agreed to acquire Riverpoint Medical for US$1.2b in cash, with an additional US$250m contingent on performance milestones. The Riverpoint deal is expected to expand Novanta’s presence in advanced surgical fibers and specialized devices, particularly minimally invasive surgical consumables across sports medicine, trauma and cardiovascular procedures. Novanta previously announced a private placement of common stock to raise about US$300m from institutional and accredited investors, with proceeds earmarked for operational and growth investments. Taken together, the Riverpoint acquisition and the earlier US$300m capital raise indicate a clear push to build out Novanta’s medical consumables footprint and support future growth projects. Investors should watch for updates on regulatory approvals, integration progress once the deal closes, and any impact on the company’s balance sheet and share count from the cash outlay and equity issuance.ナラティブの更新 • Jun 02NOVT: Future Earnings Power Will Rely On Sustaining Bookings Strength And Margin ExecutionAnalysts have lifted their fair value estimate for Novanta stock from $157 to about $171.50, citing updated models that reflect Q1 results with accelerating bookings and ongoing growth momentum. Analyst Commentary Bullish Takeaways Bullish analysts point to accelerating Q1 bookings as a key support for a higher fair value range, seeing healthier near term demand feeding into updated models.Major Estimate Revision • May 18Consensus EPS estimates increase by 15%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from US$2.16 to US$2.49. Revenue forecast steady at US$1.05b. Net income forecast to grow 102% next year vs 32% growth forecast for Electronic industry in the US. Consensus price target up from US$157 to US$172. Share price rose 9.3% to US$153 over the past week.分析記事 • May 15Novanta Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextIt's been a pretty great week for Novanta Inc. ( NASDAQ:NOVT ) shareholders, with its shares surging 14% to US$156 in...Price Target Changed • May 13Price target increased by 7.2% to US$172Up from US$160, the current price target is an average from 2 analysts. New target price is 10% above last closing price of US$155. Stock is up 18% over the past year. The company is forecast to post earnings per share of US$2.49 for next year compared to US$1.47 last year.Reported Earnings • May 12First quarter 2026 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2026 results: EPS: US$0.52 (down from US$0.59 in 1Q 2025). Revenue: US$257.7m (up 10% from 1Q 2025). Net income: US$21.1m (flat on 1Q 2025). Profit margin: 8.2% (down from 9.1% in 1Q 2025). Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Revenue is forecast to grow 5.9% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.お知らせ • May 12Novanta Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2026Novanta Inc. provided earnings guidance for the second quarter and full year of 2026. For the quarter, the company expects GAAP revenue to be in the range of $259 million to $264 million. For the year, the company expects GAAP revenue to be in the range of $1,040 million to $1,055 million.Buy Or Sell Opportunity • Apr 20Now 21% overvaluedThe stock has been flat over the last 90 days, currently trading at US$132. The fair value is estimated to be US$110, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has declined by 11%. Revenue is forecast to grow by 13% in 2 years. Earnings are forecast to grow by 107% in the next 2 years.ナラティブの更新 • Apr 19NOVT: Future Earnings Power Will Rely On Executing Stronger MarginsNarrative update on Novanta The consensus analyst price target for Novanta has been raised by $12 to $150. Analysts cite updated models after Q4 results that indicate potential for stronger sales and margin performance.お知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026ナラティブの更新 • Apr 05NOVT: Future Earnings Power Will Rely On Accelerating Sales And MarginsAnalysts have trimmed their fair value estimate for Novanta from $160 to $157, reflecting a slightly higher discount rate and a modestly lower future P/E assumption, while still pointing to expectations for improving sales and margins after recent model updates. Analyst Commentary Bullish Takeaways Bullish analysts see room for the shares to move toward their updated fair value range, supported by model revisions that assume improving sales trends and margin recovery after recent results.ナラティブの更新 • Mar 22NOVT: Future Earnings Power Will Rely On Accelerating MarginsAnalysts have lifted their price target on Novanta to $150 from $138, citing updated Q4 models that suggest the company may be positioned for faster sales growth and margin expansion. Analyst Commentary Bullish Takeaways Bullish analysts point to the raised price target to $150 as a sign that updated Q4 assumptions support a higher valuation range for the shares.Recent Insider Transactions Derivative • Mar 19Chief Financial Officer exercised options and sold US$1.0m worth of stockOn the 16th of March, Robert Buckley exercised 10k options at a strike price of around US$14.13 and sold these shares for an average price of US$117 per share. This trade did not impact their existing holding. Since June 2025, Robert's direct individual holding has increased from 127.25k shares to 132.84k. Company insiders have collectively sold US$3.8m more than they bought, via options and on-market transactions in the last 12 months.ナラティブの更新 • Mar 06NOVT: Future Earnings Power Will Rely On Accelerating MarginsAnalysts have lifted their fair value estimate for Novanta to $160 from $154, supported by updated models that reflect expectations for accelerating sales and margins following recent Q4 results and a higher Street price target of $150 from $138. Analyst Commentary Recent commentary points to a more constructive view on Novanta following its Q4 results, with updated models feeding into a higher fair value framework and a Street price target of $150.Major Estimate Revision • Mar 02Consensus EPS estimates fall by 21%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from US$2.72 to US$2.16 per share. Revenue forecast steady at US$1.04b. Net income forecast to grow 66% next year vs 28% growth forecast for Electronic industry in the US. Consensus price target up from US$154 to US$160. Share price fell 5.6% to US$134 over the past week.Recent Insider Transactions Derivative • Feb 27CEO & Chairman of the Board exercised options and sold US$721k worth of stockOn the 24th of February, Matthijs Glastra exercised options to acquire 5k shares at no cost and sold these for an average price of US$137 per share. This trade did not impact their existing holding. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since June 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 124.14k. Company insiders have collectively sold US$2.4m more than they bought, via options and on-market transactions in the last 12 months.Price Target Changed • Feb 25Price target increased by 7.0% to US$160Up from US$150, the current price target is an average from 2 analysts. New target price is 20% above last closing price of US$133. Stock is down 11% over the past year. The company is forecast to post earnings per share of US$2.16 for next year compared to US$1.47 last year.Reported Earnings • Feb 24Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: US$1.47 (down from US$1.78 in FY 2024). Revenue: US$980.6m (up 3.3% from FY 2024). Net income: US$53.8m (down 16% from FY 2024). Profit margin: 5.5% (down from 6.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.9%. Revenue is forecast to grow 6.5% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.お知らせ • Feb 24Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million. For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million.ナラティブの更新 • Feb 20NOVT: Stable Outlook Will Rely On Steady Margins And Earnings MultipleNarrative Update: Novanta Analyst Price Target The analyst price target for Novanta is unchanged at $154, as analysts keep their assumptions for fair value, discount rate, revenue growth, profit margin and future P/E essentially steady. Valuation Changes Fair Value: $154.00 remains effectively unchanged compared with the prior estimate of $154.Recent Insider Transactions Derivative • Feb 12CEO & Chairman of the Board notifies of intention to sell stockMatthijs Glastra intends to sell 8k shares in the next 90 days after lodging an Intent To Sell Form on the 10th of February. If the sale is conducted around the recent share price of US$145, it would amount to US$1.1m. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 119.25k. Company insiders have collectively sold US$1.8m more than they bought, via options and on-market transactions in the last 12 months.お知らせ • Feb 10Novanta Inc., Annual General Meeting, May 28, 2026Novanta Inc., Annual General Meeting, May 28, 2026.ナラティブの更新 • Feb 06NOVT: Equity Units Offering Will Support Balance Sheet And Future DealsAnalysts have nudged their price target on Novanta slightly higher to reflect modest tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions, framing the move as fine tuning rather than a major reset in expectations. What's in the News Novanta plans to look for acquisitions and investments, signaling an interest in adding to its portfolio of businesses (Key Developments).Recent Insider Transactions Derivative • Feb 03CEO & Chairman of the Board notifies of intention to sell stockMatthijs Glastra intends to sell 7k shares in the next 90 days after lodging an Intent To Sell Form on the 2nd of February. If the sale is conducted around the recent share price of US$135, it would amount to US$878k. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 125.75k. Company insiders have collectively sold US$1.8m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Jan 22Chief Financial Officer notifies of intention to sell stockRobert Buckley intends to sell 44k shares in the next 90 days after lodging an Intent To Sell Form on the 21st of January. If the sale is conducted around the recent share price of US$131, it would amount to US$5.8m. Since March 2025, Robert has owned 127.25k shares directly. Company insiders have collectively sold US$1.6m more than they bought, via options and on-market transactions in the last 12 months.お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026ナラティブの更新 • Jan 22NOVT: Equity Units And Share Repurchases Will Support Balance Sheet And Future DealsAnalysts now keep their price target for Novanta effectively unchanged at about $154.00. They point to steady assumptions around discount rate, revenue growth, profit margin and future P/E as the key drivers of their view.Recent Insider Transactions Derivative • Jan 11CEO & Chairman of the Board notifies of intention to sell stockMatthijs Glastra intends to sell 6k shares in the next 90 days after lodging an Intent To Sell Form on the 9th of January. If the sale is conducted around the recent share price of US$130, it would amount to US$803k. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs has owned 139.75k shares directly. Company insiders have collectively sold US$1.6m more than they bought, via options and on-market transactions in the last 12 months.ナラティブの更新 • Jan 08NOVT: Equity Units Offering Will Strengthen Balance Sheet And Support Future DealsAnalysts have maintained their fair value estimate for Novanta at approximately $154. They cite only marginal adjustments to the discount rate, long term revenue growth, profit margin assumptions, and future P/E, which do not materially change their overall outlook.ナラティブの更新 • Dec 24NOVT: New Equity Raise Will Strengthen Balance Sheet And Support Future DealsAnalysts have maintained their price target for Novanta at approximately $154 per share. This reflects a steady outlook, as incremental adjustments to discount rate assumptions and long term growth and profitability estimates are viewed as too minor to warrant a change in fair value.ナラティブの更新 • Dec 10NOVT: Expanded Equity Offering And Buybacks Will Drive Long Term Shareholder ValueAnalysts have nudged their price target for Novanta slightly higher to align with its updated fair value of $154.00, reflecting modestly stronger confidence in the company’s steady growth and margin profile. What's in the News Novanta completed a $550 million composite tangible equity units offering, issuing 11 million units priced at $50 each, with a $1.375 discount per unit (Key Developments).ナラティブの更新 • Nov 26NOVT: Expanded Buyback Authorization Will Increase Shareholder Value Going ForwardNarrative Update on Novanta: Analyst Price Target Change Analysts have maintained Novanta's fair value estimate at $154. They cited improved profitability metrics, which offset slight adjustments in the discount rate and growth projections.ナラティブの更新 • Nov 10NOVT: Equity Buyback Expansion And Profit Margin Gains Will Drive UpsideAnalysts have raised their fair value estimate for Novanta from $141.50 to $154.00 per share, citing expectations for stronger future revenue growth and improved profit margins, even though the discount rate is slightly higher. What's in the News Novanta Inc.Valuation Update With 7 Day Price Move • Nov 10Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to US$105, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 19x in the Electronic industry in the US. Total loss to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$46.01 per share.お知らせ • Nov 07Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Security Name: Units Security Type: Debt/Equity Composite Units Securities Offered: 11,000,000 Price\Range: $50 Discount Per Security: $1.375Reported Earnings • Nov 04Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: US$0.30 (down from US$0.53 in 3Q 2024). Revenue: US$247.8m (up 1.4% from 3Q 2024). Net income: US$10.7m (down 45% from 3Q 2024). Profit margin: 4.3% (down from 7.9% in 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 9.6% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 4% per year.お知らせ • Nov 04Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2025 and Fiscal Year 2026Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2025 and fiscal year 2026. For the fourth quarter of 2025, the Company expects GAAP revenue of approximately $253 million to $257 million. For the full year 2025, the Company expects GAAP revenue of approximately $975 million to $979 million. Looking forward to full year 2026, the company now expects to deliver mid-single digit organic revenue growth as a result of continued momentum in business and end markets, the strength of new design wins, and new product launches.分析記事 • Oct 28Novanta Inc. (NASDAQ:NOVT) Looks Just Right With A 30% Price JumpNovanta Inc. ( NASDAQ:NOVT ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...Valuation Update With 7 Day Price Move • Oct 26Investor sentiment improves as stock rises 22%After last week's 22% share price gain to US$129, the stock trades at a forward P/E ratio of 60x. Average forward P/E is 21x in the Electronic industry in the US. Total loss to shareholders of 9.7% over the past three years.お知らせ • Oct 08Novanta Inc. to Report Q3, 2025 Results on Nov 04, 2025Novanta Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 04, 2025分析記事 • Oct 07Is Now The Time To Look At Buying Novanta Inc. (NASDAQ:NOVT)?Novanta Inc. ( NASDAQ:NOVT ), is not the largest company out there, but it received a lot of attention from a...お知らせ • Sep 19Novanta Inc. Announces the Resignation of Barbara Hulit as Member of the Board of Directors and the Audit Committee and Environmental, Social and Governance Committee of the Board, Effective November 1, 2025Novanta Inc. announced that on September 15, 2025, Barbara Hulit resigned as a member of the Board of Directors of the company and the Audit Committee and Environmental, Social and Governance Committee of the Board, effective November 1, 2025. Ms. Hulit’s decision to resign was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.分析記事 • Sep 13Novanta's (NASDAQ:NOVT) Returns Have Hit A WallIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...ナラティブの更新 • Sep 05Robotics And Healthcare Demand Will Expand Market OpportunitiesNovanta’s fair value outlook remains unchanged, as both the discount rate and future P/E shifted only marginally, leaving the consensus analyst price target steady at $141.50. What's in the News Novanta projects third quarter 2025 GAAP revenue of $244 million to $247 million and full year 2025 GAAP revenue of $970 million to $985 million.分析記事 • Aug 29Novanta Inc.'s (NASDAQ:NOVT) Share Price Matching Investor OpinionWith a price-to-earnings (or "P/E") ratio of 69.2x Novanta Inc. ( NASDAQ:NOVT ) may be sending very bearish signals at...Major Estimate Revision • Aug 12Consensus EPS estimates fall by 32%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$2.53 to US$1.72 per share. Revenue forecast steady at US$975.6m. Net income forecast to grow 27% next year vs 30% growth forecast for Electronic industry in the US. Consensus price target down from US$150 to US$142. Share price rose 4.7% to US$121 over the past week.Reported Earnings • Aug 05Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2025 results: EPS: US$0.13 (down from US$0.38 in 2Q 2024). Revenue: US$241.0m (up 2.2% from 2Q 2024). Net income: US$4.50m (down 67% from 2Q 2024). Profit margin: 1.9% (down from 5.8% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) missed analyst estimates by 76%. Revenue is forecast to grow 6.8% p.a. on average during the next 2 years, compared to a 8.1% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 8% per year.お知らせ • Aug 05Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2025Novanta Inc. provided earnings guidance for the third quarter and full year 2025. For the quarter, the Company expects GAAP revenue of approximately $244 million to $247 million. For the full year 2025, the Company expects GAAP revenue of approximately $970 million to $985 million.お知らせ • Jul 13Novanta Inc. Announces Departure of Michele D. Welsh, General Counsel and Corporate Secretary, Effective on July 18, 2025On July 8, 2025, Novanta Inc. (the Company) announced that Michele D. Welsh, General Counsel and Corporate Secretary of the Company, would no longer serve in those positions, effective on July 18, 2025, or such earlier date as may be agreed between Ms. Welsh and the Company. There are no changes to the severance that Ms. Welsh is entitled to receive pursuant to Section 4(a)(iv) of Ms. Welsh’s employment agreement dated July 11, 2022.お知らせ • Jul 09Novanta Inc. to Report Q2, 2025 Results on Aug 05, 2025Novanta Inc. announced that they will report Q2, 2025 results on Aug 05, 2025分析記事 • Jun 16Are Novanta Inc. (NASDAQ:NOVT) Investors Paying Above The Intrinsic Value?Key Insights The projected fair value for Novanta is US$95.22 based on 2 Stage Free Cash Flow to Equity Novanta is...Price Target Changed • May 12Price target decreased by 9.4% to US$147Down from US$163, the current price target is an average from 3 analysts. New target price is 12% above last closing price of US$132. Stock is down 19% over the past year. The company is forecast to post earnings per share of US$2.48 for next year compared to US$1.78 last year.お知らせ • May 07Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million.Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million on April 8, 2025. A an initial cash payment of €60.6 million ($66.4 million), subject to customary closing and net working capital adjustments. The purchase includes up to €20.0 million ($21.9 million) in contingent consideration payable upon the achievement of certain revenue targets through December 2027. In addition, the Company has granted equity totaling €9.0 million ($9.9 million) to Keonn employees. The Keonn acquisition will be included in the Medical Solutions reportable segment. On April 8, 2025, Novanta drew down on revolving credit facility under the Senior Credit Facilities to fund the acquisition of Keonn Technologies, S.L. The acquisition was financed with cash on-hand and borrowings under Novanta's revolving credit facility. Novanta Inc. (NasdaqGS:NOVT) completed the acquisition of Keonn Technologies, S.L. on April 8, 2025.Reported Earnings • May 07First quarter 2025 earnings: EPS exceeds analyst expectationsFirst quarter 2025 results: EPS: US$0.59 (up from US$0.41 in 1Q 2024). Revenue: US$233.4m (up 1.1% from 1Q 2024). Net income: US$21.2m (up 45% from 1Q 2024). Profit margin: 9.1% (up from 6.4% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 44%. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year.お知らせ • May 06Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2025Novanta Inc. provided earnings guidance for the second quarter of 2025. For the quarter, the Company expects GAAP revenue of approximately $230 million to $240 million.お知らせ • Apr 28Novanta Inc., Annual General Meeting, May 29, 2025Novanta Inc., Annual General Meeting, May 29, 2025.Buy Or Sell Opportunity • Apr 24Now 20% overvaluedOver the last 90 days, the stock has fallen 19% to US$121. The fair value is estimated to be US$100, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 76% in the next 2 years.お知らせ • Apr 09Novanta Inc. to Report Q1, 2025 Results on May 06, 2025Novanta Inc. announced that they will report Q1, 2025 results on May 06, 2025Seeking Alpha • Apr 06Novanta: A Trusted Yet Premium Technology PartnerSummary Novanta has shown solid growth over the past decade, but growth has been a bit sluggish in recent years. The company is a key technology partner for global OEMs, with balanced revenue from advanced industrial and medical applications, boasting strong EBITDA margins. Despite a recent acquisition and increased sales, competitive dynamics, and macroeconomic challenges have pressured growth; shares are now trading at a lower, yet still premium, multiple. With debt reduced and growth returning, shares deserve a premium, but need to fall below $100 for a more attractive valuation. Read the full article on Seeking AlphaValuation Update With 7 Day Price Move • Apr 04Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to US$104, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Electronic industry in the US. Total loss to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$101 per share.Recent Insider Transactions Derivative • Feb 27CEO & Chairman of the Board exercised options and sold US$726k worth of stockOn the 24th of February, Matthijs Glastra exercised options to acquire 5k shares at no cost and sold these for an average price of US$138 per share. This trade did not impact their existing holding. For the year to December 2018, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Matthijs' direct individual holding has decreased from 148.84k shares to 134.15k. Company insiders have collectively sold US$7.7m more than they bought, via options and on-market transactions in the last 12 months.お知らせ • Feb 26Novanta Inc. Provides Earnings Guidance for the First Quarter of 2025 and Full Year 2025Novanta Inc. provided earnings guidance for the first quarter of 2025 and full year 2025. For the quarter, the company expects GAAP revenue of approximately $232 million to $236 million. For the year, the company expects GAAP revenue of approximately $1.0 billion, representing revenue growth of approximately 5% year-over-year.Reported Earnings • Feb 25Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: US$1.78 (down from US$2.03 in FY 2023). Revenue: US$949.2m (up 7.7% from FY 2023). Net income: US$64.1m (down 12% from FY 2023). Profit margin: 6.8% (down from 8.3% in FY 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 8.2% p.a. on average during the next 2 years, compared to a 7.4% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 4% per year.お知らせ • Jan 29Novanta Inc. to Report Q4, 2024 Results on Feb 25, 2025Novanta Inc. announced that they will report Q4, 2024 results on Feb 25, 2025Seeking Alpha • Jan 01Novanta: Delayed Recovery And Prolonged Struggles Ahead, Downgrade To SellSummary Novanta's Q3 results show revenue growth but a decline in gross margin and shipment deferrals, indicating prolonged challenges. Macroeconomic pressures, including weak demand and high interest rates, are hindering recovery in the life sciences sector. The company's book-to-bill ratio below 1 signals weakening demand, and its high debt levels add to the risk. Novanta’s valuation is too high given its low growth prospects, especially compared to more promising peers. As a result of these factors, Novanta is downgraded from a hold to a sell, as its current price does not justify the risks. Read the full article on Seeking AlphaPrice Target Changed • Dec 05Price target decreased by 9.0% to US$165Down from US$181, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of US$166. Stock is up 9.8% over the past year. The company is forecast to post earnings per share of US$1.76 for next year compared to US$2.03 last year.Recent Insider Transactions • Nov 14CEO & Chairman of the Board recently sold US$1.3m worth of stockOn the 11th of November, Matthijs Glastra sold around 8k shares on-market at roughly US$180 per share. This transaction amounted to 5.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Matthijs' only on-market trade for the last 12 months.Reported Earnings • Nov 07Third quarter 2024 earnings: EPS misses analyst expectationsThird quarter 2024 results: EPS: US$0.53 (down from US$0.59 in 3Q 2023). Revenue: US$244.4m (up 10% from 3Q 2023). Net income: US$19.2m (down 9.6% from 3Q 2023). Profit margin: 7.9% (down from 9.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.6%. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 3% per year.Recent Insider Transactions Derivative • Nov 06Chief Financial Officer exercised options and sold US$582k worth of stockOn the 1st of November, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$173 per share. This trade did not impact their existing holding. Since December 2023, Robert's direct individual holding has decreased from 121.56k shares to 120.42k. Company insiders have collectively sold US$5.6m more than they bought, via options and on-market transactions in the last 12 months.お知らせ • Nov 05Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 and Revenue Guidance for the Year 2025Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2024 and revenue guidance for the year 2025. For the fourth quarter of 2024, the company expects GAAP revenue of approximately $237 million to $242 million. For the full year 2024, the company expects GAAP revenue of approximately $948 million to $953 million. The company expects organic revenue growth of up to 10% in 2025 compared to 2024.お知らせ • Oct 09Novanta Inc. to Report Q3, 2024 Results on Nov 05, 2024Novanta Inc. announced that they will report Q3, 2024 results on Nov 05, 2024Recent Insider Transactions Derivative • Oct 03Chief Financial Officer notifies of intention to sell stockRobert Buckley intends to sell 27k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of October. If the sale is conducted around the recent share price of US$179, it would amount to US$4.9m. Since December 2023, Robert's direct individual holding has decreased from 121.56k shares to 120.42k. Company insiders have collectively sold US$4.5m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Sep 06Chief Financial Officer exercised options and sold US$710k worth of stockOn the 3rd of September, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$176 per share. This trade did not impact their existing holding. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$4.3m more than they bought, via options and on-market transactions in the last 12 months.Seeking Alpha • Sep 02Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A HoldSummary Novanta Inc. is a leading tech provider facing macroeconomic headwinds and a soft demand climate, which have pressured its revenue and profitability. Despite strong fundamentals and a solid market position, its current high valuation makes it a risky investment. NOVT has managed modest revenue growth but struggles with significant inflationary challenges. For now, a Hold rating is recommended as the stock's valuation does not align with its performance amidst ongoing market uncertainties. Read the full article on Seeking Alpha新しいナラティブ • Aug 28Innovative Medical Devices And Tactical Acquisitions Poised To Accelerate Company Growth Focusing on medical devices with new products might significantly boost future revenue through innovation, aiming for notable revenue from new launches by 2025. お知らせ • Aug 24Novanta Inc. Announces Executive ChangesOn August 22, 2024, John Burke, formerly Vice President of Global Accounting for Novanta Inc. (company) was appointed Chief Accounting Officer of the company and assumed the role of principal accounting officer. Mr. Burke succeeds Peter Chang, Chief Accounting Officer and Corporate Controller of the Company, who departed from the role effective August 22, 2024. Mr. Chang, who served thirteen years in the role, will serve as an advisor to the Chief Financial Officer until his anticipated departure from the Company on February 28, 2025, and will assist with the transition of the Chief Accounting Officer role. Mr. Burke, age 43, has been it’s Vice President of Global Accounting since 2021, and previously served as Vice President of Accounting from 2017 to 2021 and Assistant Corporate Controller from 2011 to 2017. Prior to joining the company, Mr. Burke worked as the Manager of Technical Accounting and Reporting at MilliporeSigma (formerly known as Millipore Corporation), and prior to that, as an audit manager in the Boston office of PricewaterhouseCoopers LLP. Mr. Burke is a Certified Public Accountant and has a Bachelor of Business Administration degree in Accounting from the University of Massachusetts-Amherst.Reported Earnings • Aug 07Second quarter 2024 earnings: EPS misses analyst expectationsSecond quarter 2024 results: EPS: US$0.38 (down from US$0.58 in 2Q 2023). Revenue: US$235.9m (up 2.8% from 2Q 2023). Net income: US$13.8m (down 34% from 2Q 2023). Profit margin: 5.8% (down from 9.1% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.5%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 7.2% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 07Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024Novanta Inc. provided earnings guidance for the third quarter and full year of 2024. For the quarter, Company expects GAAP revenue of approximately $241 millionto $244 million. For the year, the company expects GAAP revenue of approximately $975 million, representing reported revenue growth of greater than 10%.Recent Insider Transactions Derivative • Aug 06Chief Financial Officer exercised options and sold US$652k worth of stockOn the 1st of August, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$173 per share. This trade did not impact their existing holding. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$3.3m more than they bought, via options and on-market transactions in the last 12 months.Buy Or Sell Opportunity • Aug 06Now 26% overvalued after recent price riseOver the last 90 days, the stock has risen 7.3% to US$170. The fair value is estimated to be US$135, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 12% in a year. Earnings are forecast to grow by 20% in the next year.お知らせ • Jul 10Novanta Inc. to Report Q2, 2024 Results on Aug 06, 2024Novanta Inc. announced that they will report Q2, 2024 results on Aug 06, 2024Recent Insider Transactions Derivative • Jul 05Chief Financial Officer notifies of intention to sell stockRobert Buckley intends to sell 22k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of July. If the sale is conducted around the recent share price of US$163, it would amount to US$3.6m. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$2.1m more than they bought, via options and on-market transactions in the last 12 months.収支内訳Novanta の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NasdaqGS:NOVT 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費03 Apr 261,005542059531 Dec 25981541969526 Sep 25960531889827 Jun 25957611819728 Mar 25952711799631 Dec 24949641779627 Sep 24923601759428 Jun 24900621709229 Mar 24893691689231 Dec 23882731659229 Sep 23888761619030 Jun 23890771628931 Mar 23876731608831 Dec 22861741598630 Sep 22841731568301 Jul 22796641477901 Apr 22748581377531 Dec 21707501307301 Oct 21655491226902 Jul 21621441176702 Apr 21598441116431 Dec 20591451106102 Oct 20603411126003 Jul 20614421135803 Apr 20624401185731 Dec 19626411195627 Sep 19623431175428 Jun 19629561195429 Mar 19625571195331 Dec 18614511165128 Sep 18605391155029 Jun 18591181134830 Mar 18559121084431 Dec 17521401024229 Sep 1747348943830 Jun 1742555863431 Mar 1740354823331 Dec 1638522813230 Sep 1637620803101 Jul 1637119803101 Apr 1636934813131 Dec 1537436823102 Oct 153771853203 Jul 1538008632質の高い収益: NOVTには$27.7M } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が3rd April, 2026に影響を及ぼしています。利益率の向上: NOVTの現在の純利益率 (5.3%)は、昨年(7.4%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: NOVTの収益は過去 5 年間で年間2.3%増加しました。成長の加速: NOVTは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: NOVTは過去 1 年間で収益成長率がマイナス ( -23.3% ) となったため、 Electronic業界平均 ( 10.6% ) と比較することが困難です。株主資本利益率高いROE: NOVTの 自己資本利益率 ( 4.1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YTech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/12 19:48終値2026/06/12 00:00収益2026/04/03年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Novanta Inc. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Robert MasonBairdQuinn FredricksonBairdAndrew BuscagliaBerenberg5 その他のアナリストを表示
Reported Earnings • May 12First quarter 2026 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2026 results: EPS: US$0.52 (down from US$0.59 in 1Q 2025). Revenue: US$257.7m (up 10% from 1Q 2025). Net income: US$21.1m (flat on 1Q 2025). Profit margin: 8.2% (down from 9.1% in 1Q 2025). Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Revenue is forecast to grow 5.9% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026
Reported Earnings • Feb 24Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: US$1.47 (down from US$1.78 in FY 2024). Revenue: US$980.6m (up 3.3% from FY 2024). Net income: US$53.8m (down 16% from FY 2024). Profit margin: 5.5% (down from 6.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.9%. Revenue is forecast to grow 6.5% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026
Reported Earnings • Nov 04Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: US$0.30 (down from US$0.53 in 3Q 2024). Revenue: US$247.8m (up 1.4% from 3Q 2024). Net income: US$10.7m (down 45% from 3Q 2024). Profit margin: 4.3% (down from 7.9% in 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 9.6% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 4% per year.
お知らせ • Oct 08Novanta Inc. to Report Q3, 2025 Results on Nov 04, 2025Novanta Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 04, 2025
お知らせ • Jun 11Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion.Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion on June 8, 2026. A cash consideration of $1.2 billion will be paid by Novanta Inc. Novanta Inc. will pay a milestone payment of $250 million in the first quarter of 2027. Upon completion of the transaction, Riverpoint Medical will be reported under Novanta’s Medical Solutions operating segment. The transaction will be financed through a combination of cash on hand and Novanta’s existing credit facility, and the recently completed $300 million equity raise. The transaction is subject to customary regulatory approvals and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the third quarter of 2026. The transaction is expected to be immediately accretive in 2026 to Novanta’s Adjusted Diluted Earnings Per Share, and in 2027 accretive to revenue growth rate, Adjusted Gross and EBITDA Margins, Adjusted Diluted Earnings Per Share, and Operating Cash Flows. Robert W. Baird & Co. Incorporated acted as financial advisor for Novanta Inc. Jefferies LLC acted as financial advisor for Riverpoint Medical, LLC. J.P. Morgan Securities LLC acted as financial advisor for Novanta Inc. King & Spalding LLP acted as legal advisor for Novanta Inc. Matthew J. Byron, Melissa Rones, Emily Karlberg, Renata Ferrari, Pamela Glazier, Samer Musallam, Lisa Kaltenbrunner, Emerson Siegle, Deidre Johnson, Ryan Murphey, Rebecca Liu, Heather Sprague, Alison McLaughlin, and Kurt Fowler of Ropes & Gray LLP acted as legal advisor for Novanta Inc. Joshua Klatzkin, Matthew M. Mauney, and Michael Amalfe of Goodwin Procter LLP acted as legal advisor for Riverpoint Medical, LLC.
Seeking Alpha • Jun 11Novanta: An Interesting Deal Accelerates GrowthSummary Novanta announced a substantial $1.45B acquisition of Riverpoint Medical, doubling recurring medical consumables revenue and increasing medical end-market concentration to 60%. Riverpoint brings high-margin, fast-growing consumables, with 12-15% organic growth and 40% EBITDA margins, enhancing Novanta's profitability profile. Pro forma leverage rises to 2.7x; a $300M equity raise at a discount offsets some debt but results in 3% dilution. Despite strong execution and growth momentum, Novanta trades at ~40x forward earnings, leading me to remain cautious and await better entry points. Read the full article on Seeking Alpha
お知らせ • Jun 10Novanta Inc. announced that it expects to receive $299.99998 million in fundingNovanta Inc. entered into a Securities Purchase Agreement and announced a private placement of 2,142,857 Common Shares of the company at an issue price of $140 for gross proceeds up to $300.0 million on June 8, 2026. The transaction involves participation from institutional and other accredited investors. The private placement is expected to close on or about June 11, 2026, subject to satisfaction of customary closing conditions.
ライブニュース • Jun 09Novanta Expands Medical Consumables With US$1.2 Billion Riverpoint Deal and US$300 Million Capital RaiseNovanta agreed to acquire Riverpoint Medical for US$1.2b in cash, with an additional US$250m contingent on performance milestones. The Riverpoint deal is expected to expand Novanta’s presence in advanced surgical fibers and specialized devices, particularly minimally invasive surgical consumables across sports medicine, trauma and cardiovascular procedures. Novanta previously announced a private placement of common stock to raise about US$300m from institutional and accredited investors, with proceeds earmarked for operational and growth investments. Taken together, the Riverpoint acquisition and the earlier US$300m capital raise indicate a clear push to build out Novanta’s medical consumables footprint and support future growth projects. Investors should watch for updates on regulatory approvals, integration progress once the deal closes, and any impact on the company’s balance sheet and share count from the cash outlay and equity issuance.
ナラティブの更新 • Jun 02NOVT: Future Earnings Power Will Rely On Sustaining Bookings Strength And Margin ExecutionAnalysts have lifted their fair value estimate for Novanta stock from $157 to about $171.50, citing updated models that reflect Q1 results with accelerating bookings and ongoing growth momentum. Analyst Commentary Bullish Takeaways Bullish analysts point to accelerating Q1 bookings as a key support for a higher fair value range, seeing healthier near term demand feeding into updated models.
Major Estimate Revision • May 18Consensus EPS estimates increase by 15%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from US$2.16 to US$2.49. Revenue forecast steady at US$1.05b. Net income forecast to grow 102% next year vs 32% growth forecast for Electronic industry in the US. Consensus price target up from US$157 to US$172. Share price rose 9.3% to US$153 over the past week.
分析記事 • May 15Novanta Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextIt's been a pretty great week for Novanta Inc. ( NASDAQ:NOVT ) shareholders, with its shares surging 14% to US$156 in...
Price Target Changed • May 13Price target increased by 7.2% to US$172Up from US$160, the current price target is an average from 2 analysts. New target price is 10% above last closing price of US$155. Stock is up 18% over the past year. The company is forecast to post earnings per share of US$2.49 for next year compared to US$1.47 last year.
Reported Earnings • May 12First quarter 2026 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2026 results: EPS: US$0.52 (down from US$0.59 in 1Q 2025). Revenue: US$257.7m (up 10% from 1Q 2025). Net income: US$21.1m (flat on 1Q 2025). Profit margin: 8.2% (down from 9.1% in 1Q 2025). Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Revenue is forecast to grow 5.9% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
お知らせ • May 12Novanta Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2026Novanta Inc. provided earnings guidance for the second quarter and full year of 2026. For the quarter, the company expects GAAP revenue to be in the range of $259 million to $264 million. For the year, the company expects GAAP revenue to be in the range of $1,040 million to $1,055 million.
Buy Or Sell Opportunity • Apr 20Now 21% overvaluedThe stock has been flat over the last 90 days, currently trading at US$132. The fair value is estimated to be US$110, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has declined by 11%. Revenue is forecast to grow by 13% in 2 years. Earnings are forecast to grow by 107% in the next 2 years.
ナラティブの更新 • Apr 19NOVT: Future Earnings Power Will Rely On Executing Stronger MarginsNarrative update on Novanta The consensus analyst price target for Novanta has been raised by $12 to $150. Analysts cite updated models after Q4 results that indicate potential for stronger sales and margin performance.
お知らせ • Apr 14Novanta Inc. to Report Q1, 2026 Results on May 11, 2026Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026
ナラティブの更新 • Apr 05NOVT: Future Earnings Power Will Rely On Accelerating Sales And MarginsAnalysts have trimmed their fair value estimate for Novanta from $160 to $157, reflecting a slightly higher discount rate and a modestly lower future P/E assumption, while still pointing to expectations for improving sales and margins after recent model updates. Analyst Commentary Bullish Takeaways Bullish analysts see room for the shares to move toward their updated fair value range, supported by model revisions that assume improving sales trends and margin recovery after recent results.
ナラティブの更新 • Mar 22NOVT: Future Earnings Power Will Rely On Accelerating MarginsAnalysts have lifted their price target on Novanta to $150 from $138, citing updated Q4 models that suggest the company may be positioned for faster sales growth and margin expansion. Analyst Commentary Bullish Takeaways Bullish analysts point to the raised price target to $150 as a sign that updated Q4 assumptions support a higher valuation range for the shares.
Recent Insider Transactions Derivative • Mar 19Chief Financial Officer exercised options and sold US$1.0m worth of stockOn the 16th of March, Robert Buckley exercised 10k options at a strike price of around US$14.13 and sold these shares for an average price of US$117 per share. This trade did not impact their existing holding. Since June 2025, Robert's direct individual holding has increased from 127.25k shares to 132.84k. Company insiders have collectively sold US$3.8m more than they bought, via options and on-market transactions in the last 12 months.
ナラティブの更新 • Mar 06NOVT: Future Earnings Power Will Rely On Accelerating MarginsAnalysts have lifted their fair value estimate for Novanta to $160 from $154, supported by updated models that reflect expectations for accelerating sales and margins following recent Q4 results and a higher Street price target of $150 from $138. Analyst Commentary Recent commentary points to a more constructive view on Novanta following its Q4 results, with updated models feeding into a higher fair value framework and a Street price target of $150.
Major Estimate Revision • Mar 02Consensus EPS estimates fall by 21%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from US$2.72 to US$2.16 per share. Revenue forecast steady at US$1.04b. Net income forecast to grow 66% next year vs 28% growth forecast for Electronic industry in the US. Consensus price target up from US$154 to US$160. Share price fell 5.6% to US$134 over the past week.
Recent Insider Transactions Derivative • Feb 27CEO & Chairman of the Board exercised options and sold US$721k worth of stockOn the 24th of February, Matthijs Glastra exercised options to acquire 5k shares at no cost and sold these for an average price of US$137 per share. This trade did not impact their existing holding. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since June 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 124.14k. Company insiders have collectively sold US$2.4m more than they bought, via options and on-market transactions in the last 12 months.
Price Target Changed • Feb 25Price target increased by 7.0% to US$160Up from US$150, the current price target is an average from 2 analysts. New target price is 20% above last closing price of US$133. Stock is down 11% over the past year. The company is forecast to post earnings per share of US$2.16 for next year compared to US$1.47 last year.
Reported Earnings • Feb 24Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: US$1.47 (down from US$1.78 in FY 2024). Revenue: US$980.6m (up 3.3% from FY 2024). Net income: US$53.8m (down 16% from FY 2024). Profit margin: 5.5% (down from 6.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.9%. Revenue is forecast to grow 6.5% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 24Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million. For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million.
ナラティブの更新 • Feb 20NOVT: Stable Outlook Will Rely On Steady Margins And Earnings MultipleNarrative Update: Novanta Analyst Price Target The analyst price target for Novanta is unchanged at $154, as analysts keep their assumptions for fair value, discount rate, revenue growth, profit margin and future P/E essentially steady. Valuation Changes Fair Value: $154.00 remains effectively unchanged compared with the prior estimate of $154.
Recent Insider Transactions Derivative • Feb 12CEO & Chairman of the Board notifies of intention to sell stockMatthijs Glastra intends to sell 8k shares in the next 90 days after lodging an Intent To Sell Form on the 10th of February. If the sale is conducted around the recent share price of US$145, it would amount to US$1.1m. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 119.25k. Company insiders have collectively sold US$1.8m more than they bought, via options and on-market transactions in the last 12 months.
お知らせ • Feb 10Novanta Inc., Annual General Meeting, May 28, 2026Novanta Inc., Annual General Meeting, May 28, 2026.
ナラティブの更新 • Feb 06NOVT: Equity Units Offering Will Support Balance Sheet And Future DealsAnalysts have nudged their price target on Novanta slightly higher to reflect modest tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions, framing the move as fine tuning rather than a major reset in expectations. What's in the News Novanta plans to look for acquisitions and investments, signaling an interest in adding to its portfolio of businesses (Key Developments).
Recent Insider Transactions Derivative • Feb 03CEO & Chairman of the Board notifies of intention to sell stockMatthijs Glastra intends to sell 7k shares in the next 90 days after lodging an Intent To Sell Form on the 2nd of February. If the sale is conducted around the recent share price of US$135, it would amount to US$878k. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 125.75k. Company insiders have collectively sold US$1.8m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Jan 22Chief Financial Officer notifies of intention to sell stockRobert Buckley intends to sell 44k shares in the next 90 days after lodging an Intent To Sell Form on the 21st of January. If the sale is conducted around the recent share price of US$131, it would amount to US$5.8m. Since March 2025, Robert has owned 127.25k shares directly. Company insiders have collectively sold US$1.6m more than they bought, via options and on-market transactions in the last 12 months.
お知らせ • Jan 22Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026
ナラティブの更新 • Jan 22NOVT: Equity Units And Share Repurchases Will Support Balance Sheet And Future DealsAnalysts now keep their price target for Novanta effectively unchanged at about $154.00. They point to steady assumptions around discount rate, revenue growth, profit margin and future P/E as the key drivers of their view.
Recent Insider Transactions Derivative • Jan 11CEO & Chairman of the Board notifies of intention to sell stockMatthijs Glastra intends to sell 6k shares in the next 90 days after lodging an Intent To Sell Form on the 9th of January. If the sale is conducted around the recent share price of US$130, it would amount to US$803k. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs has owned 139.75k shares directly. Company insiders have collectively sold US$1.6m more than they bought, via options and on-market transactions in the last 12 months.
ナラティブの更新 • Jan 08NOVT: Equity Units Offering Will Strengthen Balance Sheet And Support Future DealsAnalysts have maintained their fair value estimate for Novanta at approximately $154. They cite only marginal adjustments to the discount rate, long term revenue growth, profit margin assumptions, and future P/E, which do not materially change their overall outlook.
ナラティブの更新 • Dec 24NOVT: New Equity Raise Will Strengthen Balance Sheet And Support Future DealsAnalysts have maintained their price target for Novanta at approximately $154 per share. This reflects a steady outlook, as incremental adjustments to discount rate assumptions and long term growth and profitability estimates are viewed as too minor to warrant a change in fair value.
ナラティブの更新 • Dec 10NOVT: Expanded Equity Offering And Buybacks Will Drive Long Term Shareholder ValueAnalysts have nudged their price target for Novanta slightly higher to align with its updated fair value of $154.00, reflecting modestly stronger confidence in the company’s steady growth and margin profile. What's in the News Novanta completed a $550 million composite tangible equity units offering, issuing 11 million units priced at $50 each, with a $1.375 discount per unit (Key Developments).
ナラティブの更新 • Nov 26NOVT: Expanded Buyback Authorization Will Increase Shareholder Value Going ForwardNarrative Update on Novanta: Analyst Price Target Change Analysts have maintained Novanta's fair value estimate at $154. They cited improved profitability metrics, which offset slight adjustments in the discount rate and growth projections.
ナラティブの更新 • Nov 10NOVT: Equity Buyback Expansion And Profit Margin Gains Will Drive UpsideAnalysts have raised their fair value estimate for Novanta from $141.50 to $154.00 per share, citing expectations for stronger future revenue growth and improved profit margins, even though the discount rate is slightly higher. What's in the News Novanta Inc.
Valuation Update With 7 Day Price Move • Nov 10Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to US$105, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 19x in the Electronic industry in the US. Total loss to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$46.01 per share.
お知らせ • Nov 07Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Security Name: Units Security Type: Debt/Equity Composite Units Securities Offered: 11,000,000 Price\Range: $50 Discount Per Security: $1.375
Reported Earnings • Nov 04Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: US$0.30 (down from US$0.53 in 3Q 2024). Revenue: US$247.8m (up 1.4% from 3Q 2024). Net income: US$10.7m (down 45% from 3Q 2024). Profit margin: 4.3% (down from 7.9% in 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 9.6% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 4% per year.
お知らせ • Nov 04Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2025 and Fiscal Year 2026Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2025 and fiscal year 2026. For the fourth quarter of 2025, the Company expects GAAP revenue of approximately $253 million to $257 million. For the full year 2025, the Company expects GAAP revenue of approximately $975 million to $979 million. Looking forward to full year 2026, the company now expects to deliver mid-single digit organic revenue growth as a result of continued momentum in business and end markets, the strength of new design wins, and new product launches.
分析記事 • Oct 28Novanta Inc. (NASDAQ:NOVT) Looks Just Right With A 30% Price JumpNovanta Inc. ( NASDAQ:NOVT ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...
Valuation Update With 7 Day Price Move • Oct 26Investor sentiment improves as stock rises 22%After last week's 22% share price gain to US$129, the stock trades at a forward P/E ratio of 60x. Average forward P/E is 21x in the Electronic industry in the US. Total loss to shareholders of 9.7% over the past three years.
お知らせ • Oct 08Novanta Inc. to Report Q3, 2025 Results on Nov 04, 2025Novanta Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 04, 2025
分析記事 • Oct 07Is Now The Time To Look At Buying Novanta Inc. (NASDAQ:NOVT)?Novanta Inc. ( NASDAQ:NOVT ), is not the largest company out there, but it received a lot of attention from a...
お知らせ • Sep 19Novanta Inc. Announces the Resignation of Barbara Hulit as Member of the Board of Directors and the Audit Committee and Environmental, Social and Governance Committee of the Board, Effective November 1, 2025Novanta Inc. announced that on September 15, 2025, Barbara Hulit resigned as a member of the Board of Directors of the company and the Audit Committee and Environmental, Social and Governance Committee of the Board, effective November 1, 2025. Ms. Hulit’s decision to resign was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
分析記事 • Sep 13Novanta's (NASDAQ:NOVT) Returns Have Hit A WallIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
ナラティブの更新 • Sep 05Robotics And Healthcare Demand Will Expand Market OpportunitiesNovanta’s fair value outlook remains unchanged, as both the discount rate and future P/E shifted only marginally, leaving the consensus analyst price target steady at $141.50. What's in the News Novanta projects third quarter 2025 GAAP revenue of $244 million to $247 million and full year 2025 GAAP revenue of $970 million to $985 million.
分析記事 • Aug 29Novanta Inc.'s (NASDAQ:NOVT) Share Price Matching Investor OpinionWith a price-to-earnings (or "P/E") ratio of 69.2x Novanta Inc. ( NASDAQ:NOVT ) may be sending very bearish signals at...
Major Estimate Revision • Aug 12Consensus EPS estimates fall by 32%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$2.53 to US$1.72 per share. Revenue forecast steady at US$975.6m. Net income forecast to grow 27% next year vs 30% growth forecast for Electronic industry in the US. Consensus price target down from US$150 to US$142. Share price rose 4.7% to US$121 over the past week.
Reported Earnings • Aug 05Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2025 results: EPS: US$0.13 (down from US$0.38 in 2Q 2024). Revenue: US$241.0m (up 2.2% from 2Q 2024). Net income: US$4.50m (down 67% from 2Q 2024). Profit margin: 1.9% (down from 5.8% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) missed analyst estimates by 76%. Revenue is forecast to grow 6.8% p.a. on average during the next 2 years, compared to a 8.1% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 8% per year.
お知らせ • Aug 05Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2025Novanta Inc. provided earnings guidance for the third quarter and full year 2025. For the quarter, the Company expects GAAP revenue of approximately $244 million to $247 million. For the full year 2025, the Company expects GAAP revenue of approximately $970 million to $985 million.
お知らせ • Jul 13Novanta Inc. Announces Departure of Michele D. Welsh, General Counsel and Corporate Secretary, Effective on July 18, 2025On July 8, 2025, Novanta Inc. (the Company) announced that Michele D. Welsh, General Counsel and Corporate Secretary of the Company, would no longer serve in those positions, effective on July 18, 2025, or such earlier date as may be agreed between Ms. Welsh and the Company. There are no changes to the severance that Ms. Welsh is entitled to receive pursuant to Section 4(a)(iv) of Ms. Welsh’s employment agreement dated July 11, 2022.
お知らせ • Jul 09Novanta Inc. to Report Q2, 2025 Results on Aug 05, 2025Novanta Inc. announced that they will report Q2, 2025 results on Aug 05, 2025
分析記事 • Jun 16Are Novanta Inc. (NASDAQ:NOVT) Investors Paying Above The Intrinsic Value?Key Insights The projected fair value for Novanta is US$95.22 based on 2 Stage Free Cash Flow to Equity Novanta is...
Price Target Changed • May 12Price target decreased by 9.4% to US$147Down from US$163, the current price target is an average from 3 analysts. New target price is 12% above last closing price of US$132. Stock is down 19% over the past year. The company is forecast to post earnings per share of US$2.48 for next year compared to US$1.78 last year.
お知らせ • May 07Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million.Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million on April 8, 2025. A an initial cash payment of €60.6 million ($66.4 million), subject to customary closing and net working capital adjustments. The purchase includes up to €20.0 million ($21.9 million) in contingent consideration payable upon the achievement of certain revenue targets through December 2027. In addition, the Company has granted equity totaling €9.0 million ($9.9 million) to Keonn employees. The Keonn acquisition will be included in the Medical Solutions reportable segment. On April 8, 2025, Novanta drew down on revolving credit facility under the Senior Credit Facilities to fund the acquisition of Keonn Technologies, S.L. The acquisition was financed with cash on-hand and borrowings under Novanta's revolving credit facility. Novanta Inc. (NasdaqGS:NOVT) completed the acquisition of Keonn Technologies, S.L. on April 8, 2025.
Reported Earnings • May 07First quarter 2025 earnings: EPS exceeds analyst expectationsFirst quarter 2025 results: EPS: US$0.59 (up from US$0.41 in 1Q 2024). Revenue: US$233.4m (up 1.1% from 1Q 2024). Net income: US$21.2m (up 45% from 1Q 2024). Profit margin: 9.1% (up from 6.4% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 44%. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year.
お知らせ • May 06Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2025Novanta Inc. provided earnings guidance for the second quarter of 2025. For the quarter, the Company expects GAAP revenue of approximately $230 million to $240 million.
お知らせ • Apr 28Novanta Inc., Annual General Meeting, May 29, 2025Novanta Inc., Annual General Meeting, May 29, 2025.
Buy Or Sell Opportunity • Apr 24Now 20% overvaluedOver the last 90 days, the stock has fallen 19% to US$121. The fair value is estimated to be US$100, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 76% in the next 2 years.
お知らせ • Apr 09Novanta Inc. to Report Q1, 2025 Results on May 06, 2025Novanta Inc. announced that they will report Q1, 2025 results on May 06, 2025
Seeking Alpha • Apr 06Novanta: A Trusted Yet Premium Technology PartnerSummary Novanta has shown solid growth over the past decade, but growth has been a bit sluggish in recent years. The company is a key technology partner for global OEMs, with balanced revenue from advanced industrial and medical applications, boasting strong EBITDA margins. Despite a recent acquisition and increased sales, competitive dynamics, and macroeconomic challenges have pressured growth; shares are now trading at a lower, yet still premium, multiple. With debt reduced and growth returning, shares deserve a premium, but need to fall below $100 for a more attractive valuation. Read the full article on Seeking Alpha
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to US$104, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Electronic industry in the US. Total loss to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$101 per share.
Recent Insider Transactions Derivative • Feb 27CEO & Chairman of the Board exercised options and sold US$726k worth of stockOn the 24th of February, Matthijs Glastra exercised options to acquire 5k shares at no cost and sold these for an average price of US$138 per share. This trade did not impact their existing holding. For the year to December 2018, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Matthijs' direct individual holding has decreased from 148.84k shares to 134.15k. Company insiders have collectively sold US$7.7m more than they bought, via options and on-market transactions in the last 12 months.
お知らせ • Feb 26Novanta Inc. Provides Earnings Guidance for the First Quarter of 2025 and Full Year 2025Novanta Inc. provided earnings guidance for the first quarter of 2025 and full year 2025. For the quarter, the company expects GAAP revenue of approximately $232 million to $236 million. For the year, the company expects GAAP revenue of approximately $1.0 billion, representing revenue growth of approximately 5% year-over-year.
Reported Earnings • Feb 25Full year 2024 earnings: Revenues and EPS in line with analyst expectationsFull year 2024 results: EPS: US$1.78 (down from US$2.03 in FY 2023). Revenue: US$949.2m (up 7.7% from FY 2023). Net income: US$64.1m (down 12% from FY 2023). Profit margin: 6.8% (down from 8.3% in FY 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 8.2% p.a. on average during the next 2 years, compared to a 7.4% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 4% per year.
お知らせ • Jan 29Novanta Inc. to Report Q4, 2024 Results on Feb 25, 2025Novanta Inc. announced that they will report Q4, 2024 results on Feb 25, 2025
Seeking Alpha • Jan 01Novanta: Delayed Recovery And Prolonged Struggles Ahead, Downgrade To SellSummary Novanta's Q3 results show revenue growth but a decline in gross margin and shipment deferrals, indicating prolonged challenges. Macroeconomic pressures, including weak demand and high interest rates, are hindering recovery in the life sciences sector. The company's book-to-bill ratio below 1 signals weakening demand, and its high debt levels add to the risk. Novanta’s valuation is too high given its low growth prospects, especially compared to more promising peers. As a result of these factors, Novanta is downgraded from a hold to a sell, as its current price does not justify the risks. Read the full article on Seeking Alpha
Price Target Changed • Dec 05Price target decreased by 9.0% to US$165Down from US$181, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of US$166. Stock is up 9.8% over the past year. The company is forecast to post earnings per share of US$1.76 for next year compared to US$2.03 last year.
Recent Insider Transactions • Nov 14CEO & Chairman of the Board recently sold US$1.3m worth of stockOn the 11th of November, Matthijs Glastra sold around 8k shares on-market at roughly US$180 per share. This transaction amounted to 5.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Matthijs' only on-market trade for the last 12 months.
Reported Earnings • Nov 07Third quarter 2024 earnings: EPS misses analyst expectationsThird quarter 2024 results: EPS: US$0.53 (down from US$0.59 in 3Q 2023). Revenue: US$244.4m (up 10% from 3Q 2023). Net income: US$19.2m (down 9.6% from 3Q 2023). Profit margin: 7.9% (down from 9.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.6%. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 3% per year.
Recent Insider Transactions Derivative • Nov 06Chief Financial Officer exercised options and sold US$582k worth of stockOn the 1st of November, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$173 per share. This trade did not impact their existing holding. Since December 2023, Robert's direct individual holding has decreased from 121.56k shares to 120.42k. Company insiders have collectively sold US$5.6m more than they bought, via options and on-market transactions in the last 12 months.
お知らせ • Nov 05Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 and Revenue Guidance for the Year 2025Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2024 and revenue guidance for the year 2025. For the fourth quarter of 2024, the company expects GAAP revenue of approximately $237 million to $242 million. For the full year 2024, the company expects GAAP revenue of approximately $948 million to $953 million. The company expects organic revenue growth of up to 10% in 2025 compared to 2024.
お知らせ • Oct 09Novanta Inc. to Report Q3, 2024 Results on Nov 05, 2024Novanta Inc. announced that they will report Q3, 2024 results on Nov 05, 2024
Recent Insider Transactions Derivative • Oct 03Chief Financial Officer notifies of intention to sell stockRobert Buckley intends to sell 27k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of October. If the sale is conducted around the recent share price of US$179, it would amount to US$4.9m. Since December 2023, Robert's direct individual holding has decreased from 121.56k shares to 120.42k. Company insiders have collectively sold US$4.5m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Sep 06Chief Financial Officer exercised options and sold US$710k worth of stockOn the 3rd of September, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$176 per share. This trade did not impact their existing holding. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$4.3m more than they bought, via options and on-market transactions in the last 12 months.
Seeking Alpha • Sep 02Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A HoldSummary Novanta Inc. is a leading tech provider facing macroeconomic headwinds and a soft demand climate, which have pressured its revenue and profitability. Despite strong fundamentals and a solid market position, its current high valuation makes it a risky investment. NOVT has managed modest revenue growth but struggles with significant inflationary challenges. For now, a Hold rating is recommended as the stock's valuation does not align with its performance amidst ongoing market uncertainties. Read the full article on Seeking Alpha
新しいナラティブ • Aug 28Innovative Medical Devices And Tactical Acquisitions Poised To Accelerate Company Growth Focusing on medical devices with new products might significantly boost future revenue through innovation, aiming for notable revenue from new launches by 2025.
お知らせ • Aug 24Novanta Inc. Announces Executive ChangesOn August 22, 2024, John Burke, formerly Vice President of Global Accounting for Novanta Inc. (company) was appointed Chief Accounting Officer of the company and assumed the role of principal accounting officer. Mr. Burke succeeds Peter Chang, Chief Accounting Officer and Corporate Controller of the Company, who departed from the role effective August 22, 2024. Mr. Chang, who served thirteen years in the role, will serve as an advisor to the Chief Financial Officer until his anticipated departure from the Company on February 28, 2025, and will assist with the transition of the Chief Accounting Officer role. Mr. Burke, age 43, has been it’s Vice President of Global Accounting since 2021, and previously served as Vice President of Accounting from 2017 to 2021 and Assistant Corporate Controller from 2011 to 2017. Prior to joining the company, Mr. Burke worked as the Manager of Technical Accounting and Reporting at MilliporeSigma (formerly known as Millipore Corporation), and prior to that, as an audit manager in the Boston office of PricewaterhouseCoopers LLP. Mr. Burke is a Certified Public Accountant and has a Bachelor of Business Administration degree in Accounting from the University of Massachusetts-Amherst.
Reported Earnings • Aug 07Second quarter 2024 earnings: EPS misses analyst expectationsSecond quarter 2024 results: EPS: US$0.38 (down from US$0.58 in 2Q 2023). Revenue: US$235.9m (up 2.8% from 2Q 2023). Net income: US$13.8m (down 34% from 2Q 2023). Profit margin: 5.8% (down from 9.1% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.5%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 7.2% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 07Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024Novanta Inc. provided earnings guidance for the third quarter and full year of 2024. For the quarter, Company expects GAAP revenue of approximately $241 millionto $244 million. For the year, the company expects GAAP revenue of approximately $975 million, representing reported revenue growth of greater than 10%.
Recent Insider Transactions Derivative • Aug 06Chief Financial Officer exercised options and sold US$652k worth of stockOn the 1st of August, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$173 per share. This trade did not impact their existing holding. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$3.3m more than they bought, via options and on-market transactions in the last 12 months.
Buy Or Sell Opportunity • Aug 06Now 26% overvalued after recent price riseOver the last 90 days, the stock has risen 7.3% to US$170. The fair value is estimated to be US$135, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 12% in a year. Earnings are forecast to grow by 20% in the next year.
お知らせ • Jul 10Novanta Inc. to Report Q2, 2024 Results on Aug 06, 2024Novanta Inc. announced that they will report Q2, 2024 results on Aug 06, 2024
Recent Insider Transactions Derivative • Jul 05Chief Financial Officer notifies of intention to sell stockRobert Buckley intends to sell 22k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of July. If the sale is conducted around the recent share price of US$163, it would amount to US$3.6m. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$2.1m more than they bought, via options and on-market transactions in the last 12 months.
